Sense Biopharma Overview

  • Founded
  • 2004

Founded
  • Status
  • Private

  • Employees
  • 2

Employees
  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $32.9K

  • Investors
  • 1

Sense Biopharma General Information

Description

Developer of an RNA interference (RNAi) technology designed to develop precision medicine. The company's technology interferes with gene expression in target cells and is focused on cancer and autoimmune diseases, enabling medical professionals to provide cures to their patients diagnosed with cancer.

Contact Information

Formerly Known As
Sirnasense
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Karl Johans Gate 16
  • 0154 Oslo
  • Norway
+47 905 00 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sense Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Oct-2019 $32.9K 000.00 00000 Completed Pre-Clinical Trials
To view Sense Biopharma’s complete valuation and funding history, request access »

Sense Biopharma Patents

Sense Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100273998-A1 Methods and compositions for modulating tissue factor Abandoned 08-Feb-2002 0000000000
US-20050096289-A1 Nucleic acids and short interference rna for mammals and tissue factor Abandoned 08-Feb-2002 0000000000

Sense Biopharma Executive Team (2)

Name Title Board Seat Contact Info
Mariann Donnum Managing Director & Administration Director
Peter Skorpil Head of Business Development
To view Sense Biopharma’s complete executive team members history, request access »

Sense Biopharma Board Members (4)

Name Representing Role Since
Camila Esguerra Ph.D Sense Biopharma Board Member 000 0000
Dag Dvergsten Sense Biopharma Board Member 000 0000
Jon Morten Melhus Sense Biopharma Board Member 000 0000
Stephen Minger Ph.D Sense Biopharma Board Member 000 0000
To view Sense Biopharma’s complete board members history, request access »

Sense Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sense Biopharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TRK Group Venture Capital Minority 000 0000 000000 0
To view Sense Biopharma’s complete investors history, request access »